Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Sarecycline vs placebo in moderate-to-severe acne vulgaris (China, Phase 3)
CTR20211314Phase 3Completed
- Sponsor
- Almirall
- Start
- Jun 2021
- Modality
- Small Molecules
- Countries
- 1
01
Overview
A Phase 3 trial of sarecycline in acne vulgaris, sponsored by Almirall. Started Jun 2021; status: completed.
02
Drugs
sarecycline
03
Conditions
acne vulgaris
Beyond the preview
Go deeper on CTR20211314.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on CTR20211314.